Tiba Medical and Spaulding Clinical Research Team Up to Bring Blood Pressure Monnitoring to Phase I Cardiac Safety Clinical Trials
July 2, 2009 ‐ Milwaukee, WI Tiba Medical and Spaulding Clinical Research announced today an important collaboration for supporting Phase I cardiac safety clinical trials.
As part of this strategic agreement, Spaulding Clinical Research has integrated Tiba Medical’s Ambulo 2400 ambulatory blood pressure monitoring (ABPM) systems into its suite of offerings. In this way, clinical trials that need to review blood pressure as a cardiac safety biomarker can now obtain, acquire, analyze, and report findings seamlessly. The ambulatory device and related software will greatly simplify and improve the frequent acquisition of blood pressure data in varying activity states. The completed solution will allow pharmaceutical companies and their Clinical Research Organization (CRO) partners to accomplish the following objectives: